do they really help PCOS patients?
Pillai A, Bang H, Green C. Methodist Family Medicine Residency Program, Houston, TX, USA. aspillai@tmh.tmc.edu BACKGROUND: Polycystic ovarian syndrome (PCOS) leads to a multitude of clinical and biochemical alterations in patients. Metformin and the thiazolidenediones (TZDs)–which have insulin-sensitizing properties–are believed to be effective in minimizing the changes caused by this syndrome. OBJECTIVES: Our goal was to assess the evidence for the use of TZDs or metformin in the treatment of PCOS patients. In addition, we sought to assess and compare the effectiveness of metformin vs TZDs in the clinical and biochemical regression of PCOS based on available randomized controlled trials (RCTs). SEARCH STRATEGY: We searched Medline (January 1966 to January 2007), PubMed (January 1954 to January 2007), Google Scholar search engine (through January 2007), and reference lists of articles. We also contacted researchers and clinicians in the field. SELECTION CRITERIA: We reviewed RCTs inv
